Myriad Genetics, Inc. (MYGN)
4.28
-0.34
(-7.36%)
USD |
NASDAQ |
Mar 27, 16:00
4.28
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Total Assets (Quarterly) : 706.60M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Abbott Laboratories | 86.71B |
| Insulet Corp. | 3.190B |
| Pacific Biosciences of California, Inc. | 784.08M |
| Tandem Diabetes Care, Inc. | 881.11M |
| iRhythm Holdings, Inc. | 1.020B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 338.60M |
| Shareholders Equity (Quarterly) | 368.00M |
| Debt to Equity Ratio | 0.5701 |
| Current Ratio | 2.486 |
| Net Debt Paydown Yield | -2.32% |